The global impact of Precision Medicine Group.
As it happens.

Impact, observations, and insights on the evolving healthcare landscape.

Precision for Medicine and Trialbee Partner to Advance Clinical Trials for Complex Therapies and Speed Shift Toward Precision Medicine

2021-08-05T16:05:51-04:00News, Press Releases|

MALMO, SWEDEN & BETHESDA, MD — August 5, 2021 – Clinical research organization Precision for Medicine and Trialbee, a patient matching and enrollment platform, are addressing complexities in clinical development through a new partnership that will accelerate the future of precision medicine. Trialbee’s advanced analytics will play a critical role in matching patients to trials conducted by Precision for Medicine and extending recruitment to a more diverse, targeted patient community for the development of complex, personalized medicine.


Bigger and Better Together: PRECISIONeffect Acquires Pascāle, Expanding Capabilities with PR and Social Media Services

2021-08-03T08:49:24-04:00News, Press Releases|

Boston – August 3, 2021 – PRECISIONeffect, the industry’s only healthcare advertising agency dedicated to changing the standard of care, today announced that it has acquired Pascāle, an international healthcare communications company specializing in public relations and social media. Pascāle has an almost two-decade history of launching full-scale, creative-fueled PR and social media campaigns to drive results for healthcare clients worldwide.


Precision for Medicine Acquires EganLee, Expands Foothold in the Asia-Pacific (APAC) market


We are excited to announce that EganLee, an Australian-based firm providing a range of clinical trial services for the pharmaceutical, biotechnology, medical device and CRO industries has joined the Precision family! With strong, established relationships with numerous AsiaPac research sites, the acquisition of EganLee expands Precision’s clinical trial footprint in AsiaPac.


Precision Value & Health Acquires Global Omnichannel Engagement Leader, Across Health

2021-03-23T23:23:57-04:00News, Press Releases|

EU-based team brings a unique omnichannel optimization platform and digital transformation capabilities to leading life-sciences companies

BETHESDA, MDMarch 24, 2021—Precision Value & Health, the industry leader for commercialization services for innovative life science companies, today announced that it has acquired Across Health. Across Health is a leading global omnichannel engagement consultancy focused on providing clients an analytical and evidence-based framework for commercial strategy, execution, and resource optimization. The company’s solutions are based around its proprietary, market-leading Navigator365 product suite, which more than 40 pharmaceutical companies rely on for omnichannel planning and resource allocation. The Across Health team is already working hand-in-hand with Precision’s medical communications, creative, and data sciences teams to offer analytically driven launch and commercialization programs across the product life cycle.


MM&M Hall of Femme 2019 Honors Carolyn Morgan


We are excited to share that Carolyn Morgan, president of Precisioneffect, will be inducted into the MM&M Hall of Femme. This program honors honor standout U.S. healthcare commercial executives who have made a significant impact on their organization’s success in the past year. 


Precision for Medicine Acquires Industry-leading Artificial Intelligence Technology, Significantly Expands Cloud-based Multiomic Data Integration and Informatics Platform QuartzBio™

2020-07-23T16:13:47-04:00News, Press Releases|


Bethesda, MD – March 6, 2019 – Precision for Medicine, part of Precision Medicine Group, today announced the acquisition of SimplicityBio, adding artificial intelligence to Precision’s QuartzBio™ multiomic data integration and informatics platform. The addition of an artificial intelligence engine to QuartzBio provides Precision’s clients the most robust, sophisticated end-to-end solution for the “big data” challenge observed in biomarker-guided drug development—furthering their mission of maximizing the value and utility of biomarker data generated in the course of a clinical trial.


Load More Posts